Mendlein joins Moderna in strategy role

mRNA company Moderna Therapeutics Inc. (Cambridge, Mass.) hired John Mendlein as president of corporate and product strategy. He will report to CEO Stéphane Bancel and will be responsible for corporate strategy; product advancement and strategy; partnering; and product protection.

Mendlein was CEO of aTyr Pharma Inc. (NASDAQ:LIFE) until November 2017. He has been a Moderna director since 2012 and will remain on the board. Mendlein is also joining the company's executive committee...